On the stock market since 1980, it operates in the everyday-essentials business. It has 1,003 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
The biggest line carries real weight, but it doesn’t decide everything on its own.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
An investor who bought at the very peak is down 90% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $342.3M a year. A small number, but proof the product has real buyers.
The average analyst price target is $3.00 — 134% above today’s price.
A loss of $14.5M against $342.3M in annual sales.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
Over the last 12 months, executives reported 30 sells against just 6 buys. Not an alarm bell by itself, but a number worth watching.
On our five-subject report card, FARM sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: FARM is a high-risk stock — not yet profitable, and its future rides on its product catching on.